Weekly Digest – August 2026 Weekly Digest – August 2026 07 August 2026: Hengrui’s Aiweida receives NMPA approval for HER2-positive Colorectal cancer Hengrui Pharma’s HER2-targeted ADC Aiweida has been approved in China for the treatment of adults with HER2-positive colorectal […]